JPRN-UMIN000001650已完成未知
A prospective,multicenter, randomized, parallel-group,open-label study of aripiprazole in the management of patients with schizophrenia - Chiba Broad Effectiveness Trial With Aripiprazole (Chiba-BETA)
Department of Psychiatry, Graduate School of Medicine, Chiba University0 个研究点目标入组 300 人开始时间: 2009年1月22日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 300
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18years-old 至 65years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Pregnant or breastfeeding women. Not noticed as schizophrenia. With diabetes.
研究者
相似试验
进行中（未招募）
1 期
DEFIBROTIDE AS PREVENTION AND TREATMENT OF RESPIRATORY DISTRESS AND CYTOKINE RELEASE SYNDROME OF COVID-19COVID-19EUCTR2020-001409-21-ESFFIS120
已完成
Unknown
clinical trial on Attention Deficit Hyperactivity Disorder subjectCTRI/2023/05/052517Jagdale industries pvt. Ltd100
招募中
2 期
A comparative clinical study to evaluate efficacy and safety of test drug in patients with Acute Ischemic strokeCTRI/2021/06/034395Reliance Life Sciences Pvt Ltd
已完成
3 期
A multi-center, Phase- III clinical trial of Molnupiravir capsules.CTRI/2021/05/033693ATCO Pharma Limited667
进行中（未招募）
3 期
A clinical study to estimate the efficacy and safety of formulation of Molnupiravir in patients with Mild COVID-19 infection.CTRI/2021/06/033992Optimus Pharma Pvt Ltd